Clinical Outcomes and Health Care Utilization in Patients With Burkitt Lymphoma

被引:0
|
作者
Johnson, P. Connor [1 ,2 ,7 ]
Markovitz, Netana H. [2 ,3 ]
Yi, Alisha [1 ,2 ]
Horick, Nora [2 ,4 ]
Newcomb, Richard A. [1 ,2 ]
Cronin, Katherine [5 ]
Schneider, David [5 ]
Nipp, Ryan D. [6 ]
El-Jawahri, Areej [1 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Med, Div Hematol Oncol, Boston, MA 02214 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Stat, Boston, MA USA
[5] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA
[6] Univ Oklahoma, Stephenson Canc Ctr, Dept Med, Oklahoma City, OK USA
[7] Massachusetts Gen Hosp, Canc Ctr, 55 Fruit St,Yawkey 9A, Boston, MA 02114 USA
关键词
B-CELL LYMPHOMA; OLDER PATIENTS; GERIATRIC ASSESSMENT; ADULTS; MORTALITY; SURVIVAL; CHILDREN; ALBUMIN;
D O I
10.1200/OP.23.00146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE Burkitt lymphoma is an aggressive B-cell lymphoma requiring intensive therapy, which places patients at risk for severe toxicity. However, few studies have described these patients' clinical outcomes and health care utilization, particularly among older adults.METHODS We conducted a retrospective analysis of adults 40 years and older with Burkitt lymphoma at Massachusetts General Hospital and Dana-Farber Cancer Institute from February 1999 to December 2020 (N = 97). We abstracted patient characteristics, clinical outcomes, and health care utilization (unplanned hospitalizations, intensive care unit [ICU] admissions) during therapy from the electronic health record. Using univariate logistic regression, we examined factors associated with rates of unplanned hospitalization and ICU admission during therapy.RESULTS Among evaluable patients (median age, 69 years; 23.7% female; 19.3% with bone marrow involvement), 45.8% (38 of 83) experienced unplanned hospitalization and 23.2% (19 of 82) experienced ICU admission during therapy. Among those 70 years and older, rates of unplanned hospitalization and ICU admission were 36.8% (14 of 38) and 29.0% (11 of 38), respectively. Bone marrow involvement (odds ratio [OR], 3.00; P = .069) was associated with a nonsignificantly greater likelihood of unplanned hospitalization. Older age (OR, 1.06; P = .039), Charlson comorbidity index >0 (OR, 3.14; P = .038), and hypoalbuminemia (OR, 3.22; P = .035) were associated with greater likelihood of ICU admission. Overall, 8.7% (8 of 92) of patients died during treatment, all of whom were 70 years and older.CONCLUSION Adults with Burkitt lymphoma experience substantial rates of unplanned hospitalizations and ICU admissions, with older adults at especially high risk for ICU admission and death during treatment. Our findings underscore the need to develop supportive care interventions for patients with Burkitt lymphoma to help improve clinical outcomes and health care utilization.
引用
收藏
页码:759 / +
页数:9
相关论文
共 50 条
  • [41] Outcomes of Burkitt lymphoma with bone marrow involvement or Burkitt leukemia in Chinese children
    Zhu, Jia
    Zhen, Zijun
    Wang, Juan
    Sun, Feifei
    Lu, Suying
    Huang, Junting
    Zhang, Yizhuo
    Sun, Xiaofei
    PEDIATRIC INVESTIGATION, 2021, 5 (02) : 112 - 117
  • [42] Radiotherapy for Secondary CNS Lymphoma: Patterns of Utilization and Clinical Outcomes
    Cederquist, Gustav Y.
    Tringale, Kathryn R.
    Hajj, Carla
    Hubbeling, Harper
    Fregonese, Beatrice
    Lee, Jisun
    Scordo, Michael
    Grommes, Christian
    Yahalom, Joachim
    Imber, Brandon S.
    BLOOD, 2022, 140 : 6683 - 6684
  • [43] Health care utilization in patients with spondyloarthropathies
    Singh, J. A.
    Strand, V.
    RHEUMATOLOGY, 2009, 48 (03) : 272 - 276
  • [44] Health Care Utilization in Patients with Gout
    Singh, Jasvinder A.
    Sarkin, A.
    Shieh, M.
    Khanna, D.
    Terkeltaub, R.
    Lee, S. J.
    Kavanaugh, A.
    Hirsch, J. D.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 40 (06) : 501 - 511
  • [45] TUMOUR IMMUNITY IN PATIENTS WITH BURKITT LYMPHOMA
    BLACK, MM
    LANCET, 1970, 1 (7661): : 1393 - &
  • [46] TUMOUR IMMUNITY IN PATIENTS WITH BURKITT LYMPHOMA
    不详
    LANCET, 1970, 1 (7655): : 1033 - +
  • [47] A DESCRIPTIVE ANALYSIS OF THE HEALTH CARE UTILIZATION AND COSTS OF PATIENTS DIAGNOSED WITH LYMPHOMA IN THE US MEDICARE POPULATION
    Ogbomo, A.
    Lin, Y.
    Wang, Y.
    Xie, L.
    Yuce, H.
    Baser, O.
    VALUE IN HEALTH, 2017, 20 (05) : A130 - A130
  • [48] Burkitt Lymphoma of the Appendix with an Insidious Clinical Picture
    Perysinakis, Iraklis
    Pappis, Harilaos C.
    INDIAN JOURNAL OF SURGERY, 2019, 81 (04) : 394 - 396
  • [49] Burkitt Lymphoma of the Appendix with an Insidious Clinical Picture
    Iraklis Perysinakis
    Harilaos C. Pappis
    Indian Journal of Surgery, 2019, 81 : 394 - 396
  • [50] Differences in health care costs and utilization: BR vs RCHOP in patients with follicular lymphoma.
    Zhou, Jifang
    Pathak, Ashutosh K.
    Brander, Danielle M.
    Gabriel, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35